women with advanced cervical cancer – the most common cancer afflicting young women – are to get the first officially approved new treatment for a decade . cervical cancer , which is cancer of the neck of the womb , is the most common cancer in women aged 35 and under . ‘ for a young mother sitting in front of you with small children , or indeed any patient with cancer , that length of time can be extremely important . ’ robert music , chief executive of jo’s cervical cancer trust , said ‘ this regulatory decision for avastin is positive news . to date , prognosis for women who receive a late-stage diagnosis of cervical cancer has often been poor .